Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Genetics in Medicine
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • RSS feed
  1. nature
  2. genetics in medicine
  3. abstracts
  4. article
Experience with Mucolipidosis Type IV in Newfoundland
Download PDF
Download PDF
  • Abstracts
  • Published: 01 January 1999

Abstract

Experience with Mucolipidosis Type IV in Newfoundland

  • C Prasad1,
  • D J Buckley2,
  • C Pushpanathan3,
  • E J Ives1,
  • E Goldin4 &
  • …
  • R Schiffinann5 

Genetics in Medicine volume 1, page 51 (1999)Cite this article

  • 299 Accesses

  • Metrics details

Abstract

Mucolipidosis type IV is a unique autosomal recessive progressive neurodegenerative disorder of unknown etiology. There is minimal facial dysmorphism and absence of organomegaly. Most patients reported are of Ashkenazi Jewish descent.

We present two patients from northern Newfoundland with significant developmental and speech delay, ataxia, corneal clouding, and absence of organomegaly. The skin biopsy was significant for the presence of lamellar inclusions which exhibited autofluorescence characteristic of Mucolipidosis IV cells. Cranial MRI showed changes in signal intensity consistent with increased ferritin deposition in the thalamus in one of the patients (female) but was normal in the second (male). Both the patients did not show any changes in the white matter, nor hypoplasia of the corpus callosum. Both patients had elevated serum gastrin levels, 936 and 332 pmol/L (0-43 pmol/L) respectively. The finding of high serum gastrin in patients with Mucolipidosis IV has been recently reported by Schiffmann R et al (Proc Natl Acad Sci USA 1998 Feb 3;95(3): 1207-12). This finding in combination with the characteristic skin biopsy findings can be diagnostic for this disorder.

Our patients belong to the same geographical area. They are not of Ashkenazi Jewish ancestry. Both the patients exhibit a milder course without neurological deterioration. They lack the typical cranial MRI findings of cerebellar atrophy and hypoplastic corpus callosum reported recently.

With the availability of reliable diagnostic testing, the pathogenesis and etiology of this poorly understood condition will likely be delineated in the future.

Article PDF

Author information

Authors and Affiliations

  1. Division of Medical Genetics, Bethesda, MD

    C Prasad & E J Ives

  2. Pediatric Neurology Program, Bethesda, MD

    D J Buckley

  3. Department of Pathology, Janeway Child Health Centre, St. John's, Newfoundland, Canada

    C Pushpanathan

  4. Developmental and Metabolic Neurology Branch, NINDS, NIH, Bethesda, MD

    E Goldin

  5. Developmental and Metabolic Neurology Branch, NINDS, NIH, Bethesda, MD

    R Schiffinann

Authors
  1. C Prasad
    View author publications

    Search author on:PubMed Google Scholar

  2. D J Buckley
    View author publications

    Search author on:PubMed Google Scholar

  3. C Pushpanathan
    View author publications

    Search author on:PubMed Google Scholar

  4. E J Ives
    View author publications

    Search author on:PubMed Google Scholar

  5. E Goldin
    View author publications

    Search author on:PubMed Google Scholar

  6. R Schiffinann
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prasad, C., Buckley, D., Pushpanathan, C. et al. Experience with Mucolipidosis Type IV in Newfoundland. Genet Med 1, 51 (1999). https://doi.org/10.1097/00125817-199901000-00040

Download citation

  • Issue date: 01 January 1999

  • DOI: https://doi.org/10.1097/00125817-199901000-00040

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Genetics in Medicine (Genet Med)

ISSN 1530-0366 (online)

ISSN 1098-3600 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited